These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2669473)

  • 21. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Minipress in the treatment of arterial hypertension in light of results from a multicenter study. II. Results of long-term monotherapy].
    Sznajderman M
    Kardiol Pol; 1989; 32(7-9):394-403. PubMed ID: 2701010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The antihypertensive response to prazosin, a selective vascular alpha blocker. A multicenter study].
    Pérez-Olea J; Prat H; Román O; Román O; Zarate LH; Cabello H; Quevedo M; Fuentes S; Reinback R; Chadid P
    Rev Med Chil; 1990 Feb; 118(2):164-70. PubMed ID: 2152716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive efficacy of guanfacine and prazosin in patients with mild to moderate essential hypertension.
    Lewin A; Alderman MH; Mathur P
    J Clin Pharmacol; 1990 Dec; 30(12):1081-7. PubMed ID: 2273080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
    Zanchetti A
    Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of doxazosin GITS and standard doxazosin in the treatment of high blood pressure.
    Os I
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):99-106. PubMed ID: 16550731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cumulative experience with terazosin administered in combination with diuretics.
    Rudd P
    Am J Med; 1986 May; 80(5B):49-54. PubMed ID: 2872807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
    Toal CB
    Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
    Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR; Bravo EL; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.